Nahdi Medical Company
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Saudi Arabia.
P/E ratio
13.5Investors pay 13.5 for every 1 of Nahdi Medical Company's yearly profit, lower than 71% of Healthcare companies in Saudi Arabia.
P/B ratio
4.24The share price is 4.24 times Nahdi Medical Company's book value per share, higher than 79% of Healthcare companies in Saudi Arabia.
Market cap
SAR 10.7 BThe total market value of all of Nahdi Medical Company's shares at today's price (share price × number of shares), larger than 79% of Healthcare companies in Saudi Arabia. PosiCap size class: Meso Cap.
Return on equity (ROE)
30.3%Nahdi Medical Company earned 30.3% on its shareholders' money over the last year, higher than 95% of Healthcare companies in Saudi Arabia.
Dividend yield
6.09%Nahdi Medical Company pays 6.09% of its share price as dividends a year, higher than 88% of dividend-paying Healthcare companies in Saudi Arabia.
Questions
What is Nahdi Medical Company's P/E ratio?
Investors pay 13.5 for every 1 of Nahdi Medical Company's yearly profit, lower than 71% of Healthcare companies in Saudi Arabia.
What is Nahdi Medical Company's return on equity?
Nahdi Medical Company earned 30.3% on its shareholders' money over the last year, higher than 95% of Healthcare companies in Saudi Arabia.
Does Nahdi Medical Company pay a dividend?
Yes. Nahdi Medical Company pays 6.09% of its share price as dividends a year, higher than 88% of dividend-paying Healthcare companies in Saudi Arabia.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.